Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07642869 · ClinicalTrials.gov registry record · NA
Multivitamin and Mineral Supplementation and Healthy Aging
A NA study, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07642869: Recruiting NA study, sponsored by University of California, San Diego.
NCT07642869 is a NA study that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07642869, a NA study, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of this study is to determine the impact of MVM supplementation on clinical and biochemical markers associated with healthy aging, with a particular focus on mitochondrial function and metabolism. Specifically, changes in mitochondrial respiration using isolated blood cells will be measured. This method has been used to compare with various other age-related markers of health such as physical function, gait speed, and resting metabolic rate. It is hypothesize that MVM supplementation will impact the function of blood cells. MVM supplementation impacts other markers of health, including serum nutrient levels, metabolomic profiles, physical function, and skeletal muscle composition and quality will be explored. These comprehensive assessments will provide insights into the potential benefits of MVM supplementation for healthy aging and address critical gaps in our understanding of its immediate effects. Further, this study will aid in the understanding of how multivitamin supplements can support heathy aging in mid-life adults, a key time to start including wellness programs in people's lives. The study cohort will consist of 150 sedentary men and women aged 40-60-years of age. A double-blind, three-arm, placebo-controlled randomized clinical trial will be conducted. Participants will receive a daily oral tablet containing one of two possible formulations of vitamins and minerals or a placebo. The three groups will be MVM "GOLD" blend formula, the US Restage MVM "US CORE", and the placebo group.
Primary Outcome
Multivitamin and mineral supplementation may have an impact on blood cell bioenergetics. The high-resolution Oroboros Oxygraph 2k as well as high throughput Seahorse will be used to measure maximal oxidative phosphorylation (Max OXPHOS) in freshly prepared PBMCs. Max OXPHOS is the highest measured rate of mitochondrial ATP production and is measured in picomols of oxygen per time weight, or pmol/s\*mg. This measurement will be taken at baseline and after completion of the study supplementation.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT MVM Core Blend
- DIETARY_SUPPLEMENT MVM Gold Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-09-05 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07642869 shows while recruiting
NCT07642869 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07642869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07642869 about?
NCT07642869 is a clinical study titled "Multivitamin and Mineral Supplementation and Healthy Aging". The goal of this study is to determine the impact of MVM supplementation on clinical and biochemical markers associated with healthy aging, with a particular focus on mitochondrial function and metabolism. Specifically, changes in mitochondrial respiration using isolated blood cells will be measured...
What is the current status of trial NCT07642869?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-09-05. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07642869?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), MVM Core Blend (DIETARY_SUPPLEMENT), MVM Gold Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07642869?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07642869's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI